VISION Data Report 2022

VI. Recurrence of Primary Tumor The Recurrence of Primary Tumor section provides an understanding of recurrence of the primary tumor for patients whose information and experiences have been shared with VISION. The data included in this section is in three categories: Timing of Diagnosis, Treatment and Surveillance.

What treatment did the patient have for the recurrence of the primary tumor in the affected eye? 50%

50% Surgery (enucleation or other surgical procedure) 0% Radiation

Other (laser)

Recurrence After primary treatment of the eye tumor was there recurrence (tumor growth) in the affected eye?*

0% Combination

The 3% of patients who responded “Yes” reported that primary tumor recurrence in the affected eye occured:

95%

Within three years of primary diagnosis Within two years of primary diagnosis Within 6 months of primary diagnosis Within one year of primary diagnosis

50%

0%

50%

0%

3%

2%

Greater than three years 0%

Yes

No

Unknown

* Please note: the questions in this section are answered from the time point of recurrence of the primary ocular melanoma.

2022 VISION Registry Data Report

39

Made with FlippingBook Ebook Creator